Kane Biotech's market cap is currently C$13.75M. The company's EPS TTM is C$-0.034; its P/E ratio is ―; Kane Biotech is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 148.98K	C$ 2.67M	C$ 1.61M	C$ 1.34M	C$ 1.69M
Gross Profit	C$ 109.47K	C$ 1.41M	C$ 568.44K	C$ 526.86K	C$ 609.91K
Operating Income	C$ -3.36M	C$ -3.36M	C$ -4.88M	C$ -4.22M	C$ -3.59M
EBITDA	C$ -3.23M	C$ -2.95M	C$ -4.25M	C$ -3.65M	C$ -764.08K
Net Income	C$ -5.03M	C$ -3.89M	C$ -4.60M	C$ -3.72M	C$ -960.18K
Balance Sheet
Cash & Short-Term Investments	C$ 749.25K	C$ 1.10M	C$ 1.15M	C$ 1.01M	C$ 834.13K
Total Assets	C$ 5.68M	C$ 5.62M	C$ 6.13M	C$ 5.04M	C$ 2.76M
Total Debt	C$ 9.26M	C$ 6.86M	C$ 4.71M	C$ 2.25M	C$ 169.81K
Net Debt	C$ 8.51M	C$ 5.75M	C$ 3.56M	C$ 1.24M	C$ -664.31K
Total Liabilities	C$ 14.09M	C$ 9.76M	C$ 7.70M	C$ 3.96M	C$ 1.92M
Stockholders' Equity	C$ -10.56M	C$ -6.52M	C$ -3.89M	C$ -1.49M	C$ 836.81K
Cash Flow
Free Cash Flow	C$ -3.23M	C$ -3.13M	C$ -2.64M	C$ -4.07M	C$ -1.05M
Operating Cash Flow	C$ -3.22M	C$ -3.04M	C$ -2.29M	C$ -3.94M	C$ -955.37K
Investing Cash Flow	C$ -116.14K	C$ -107.55K	C$ -373.55K	C$ -166.11K	C$ -97.38K
Financing Cash Flow	C$ 2.98M	C$ 3.10M	C$ 2.81M	C$ 4.28M	C$ 1.81M

Currency in CAD

Kane Biotech Earnings and Revenue History

Income Statement >

Kane Biotech Debt to Assets

Balance Sheet >

Kane Biotech Cash Flow

Cash Flow >

Kane Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing